Burden of Disease Study of Patients with Neovascular Age-Related Macular Degeneration in Spain-Reference-Cited by-同舟云学术

Burden of Disease Study of Patients with Neovascular Age-Related Macular Degeneration in Spain

Published:2024-05-21 Issue:7 Volume:13 Page:1925-1935
ISSN:2193-8245
Container-title:Ophthalmology and Therapy
language:en
Short-container-title:Ophthalmol Ther

Author:

Abraldes Maximino J.,Calvo Pilar,Gámez Lechuga María,Merino María^ORCID,Martín Lorenzo Teresa,Maravilla-Herrera Paulina,Gil Jiménez Beatriz,Ruiz-Moreno José M.

Funder

Roche Farma S.A.

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40123-024-00960-9.pdf

Reference33 articles.

1. Ruiz-Moreno JM, Arias Barquet L, Armadá Maresca F, et al. Tratamiento de la Degeneración Macular Asociada a la Edad (DMAE) Exudativa y Atrófica. Guías de Práctica Clínica de la SERV. 2009. www.serv.es. Accessed 2019 Sept 30.

2. Viggiano P, Grassi MO, Pignataro M, et al. Topographical analysis of the choriocapillaris reperfusion after loading anti-VEGF therapy in neovascular AMD. Transla Vis Sci Technol. 2022;11(9):18.

3. Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106–16.

4. Szabo SM, Janssen PA, Khan K, Lord SR, Potter MJ. Neovascular AMD: an overlooked risk factor for injurious falls. Osteoporos Int. 2010;21(5):855–62.

5. Arias Barquet L, Esteban Vega AI, García Arumí J, et al. Objetivo DMAE. Situación actual y propuestas de mejora para la atención sociosanitaria de la DMAE. Barcelona: Nephila Health Partnership, S.L.; 2020. https://www.novartis.es/sites/www.novartis.es/files/Objetivo-DMAE-Informe%20interactivo%20final%20280920.pdf. Accessed 2020 Oct 14.